ArticlePharmaceutics2023

The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn's Disease with Infliximab.

Marla C Dubinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.